• 1
    Robbins KC. A study on the conversion of fibrinogen to fibrin. Am J Physiol 1944; 142: 5818.
  • 2
    Laki K, Lorand L. On the solubility of fibrin clots. Science 1948; 108: 280.
  • 3
    Sarvary A, Szucs S, Balogh I et al. Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis. Cell Immunol 2004; 228: 8190.
  • 4
    Matthias N, Sosnovik D, Waterman P et al. Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res 2007; 100: 121825.
  • 5
    Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 2003; 102: 44102.
  • 6
    Asahina T, Kobayashi T, Okada Y et al. Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta 2000; 21: 38893.
  • 7
    Anwar R, Miloszewski KJ. Factor XIII deficiency. Br J Haematol 1999; 107: 46884.
  • 8
    Muszbek L, Ariens RA, Ichinose A, On behalf of the ISTH SSC Subcommittee on Factor XIII. Factor XIII: recommended terms and abbreviations. J Thromb Haemost 2007; 5: 1813.
  • 9
    Duckert F, June E, Schmerling DH. A hitherto undescribed congenital hemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh 1960; 5: 17986.
  • 10
    Schroeder V, Durrer D, Meili E, Schubiger G, Kohler H. Congenital factor XIII deficiency in Switzerland. Swiss Med Wkly 2007; 137: 2728.
  • 11
    McDonaghJ. Structure and function of factor XIII. In: ColmanRW, HirshJ, MarderVJ, SalzmanEW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd edn. Philadelphia, PA: Lippincott Company: 1994: 30111.
  • 12
    Board PG, Webb GC, McKee J, Ichinose A. Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24–p25. Cytogenet Cell Genet 1988; 48: 257.
  • 13
    Yee V, Trong I, Bishop P, Pedersen L, Stenkamp R, Teller D. Structure and function studies of factor XIIIA by x-ray crystallography. Semin Thromb Hemost 1996; 22: 37784.
  • 14
    Pedersen LC, Yee VC, Bishop PD, Le Trong I, Teller DC, Stenkamp RE. Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules. Protein Sci 1994; 3: 11315.
  • 15
    IchinoseA. The physiology and biochemistry of factor XIII. In: BloomAL, ForbesCD, ThomasDP, TuddenhamEGD, eds. Haemostasis and Thrombosis, Vol. 1, 3rd edn. Edinburgh: Livingstone, 1994: 53146.
  • 16
    Board PG, Losowsky MS, Miloszewski KJA. Factor XIII: inherited and acquired deficiency. Blood Rev 1993; 7: 22942.
  • 17
    Mosesson MW, Siebenlist KR, Hernandez I, Lee KN, Christiansen VJ, McKee PA. Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation. J Thromb Haemost 2008; 6: 156770.
  • 18
    Polgar J, Hidasi V, Muszbek L. Non-proteolytic activation of cellular protransglutaminase. Biochem J 1990; 267: 55760.
  • 19
    Wölpl A, Lattke H, Board PG et al. Coagulation factor XIII A and B subunits in bone marrow and liver transplantation. Transplantation 1987; 43: 1513.
  • 20
    Bottenus RE, Ichinose A, Davie EW. Nucleotide sequence of the gene for the B subunit of human factor XIII. Biochemistry 1990; 29: 11195209.
  • 21
    Webb GC, Coggan M, Ichinose A, Board PG. Localization of the coagulation factor XIIIB subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus. Hum Genet 1989; 81: 15760.
  • 22
    Siebenlist KR, Meh DA, Mosesson MW. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry 1996; 35: 1044853.
  • 23
    Greenberg CS, Miraglia CC, Rickles FR et al. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. J Clin Invest 1998; 75: 146370.
  • 24
    Mosesson MW. Fibrinogen gamma chain functions. J Thromb Haemost 2003; 1: 2318.
  • 25
    Moaddel M, Farrell DH, Daugherty MA et al. Interactions of human fibrinogens with factor XIII: roles of calcium and the gamma’ peptide. Biochemistry 2000; 39: 6698705.
  • 26
    Koseki S, Souri M, Koga S et al. Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation. Blood 2001; 97: 266772.
  • 27
    Gomez Garcia EB, Poort SR, Stibbe J. Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiency. Br J Haematol 2001; 112: 5138.
  • 28
    Anwar R, Gallivan L, Trinh C, et al. Identification of a new Leu354Pro mutation responsible for factor XIII deficiency. Eur J Haematol 2001;66: 1336.
  • 29
    McCormack LJ, Kain K, Catto AJ, Kohler HP, Stickland MH, Grant PJ. Prevalence of FXIII V34L in populations with different cardiovascular risk. Thromb Haemost 1998; 80: 5234.
  • 30
    Attié-Castro FA, Zago MA, Lavinha J et al. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost 2000; 84: 6013.
  • 31
    Kohler HP, Ariens RA, Whitaker P, Grant PJ. A common coding polymorphism in the FXIII-A subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 1998; 80: 704.
  • 32
    Reiner AP, Schwartz SM, Frank MB et al. Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women. Stroke 2001; 32: 25806.
  • 33
    Anwar R, Gallivan L, Edmonds SD, Markhan AF. Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 1999; 93: 897905.
  • 34
    Kohler HP, Stickland LH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 813.
  • 35
    Wartiovaara U, Mikkola H, Szôke G et al. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost 2000; 84: 595600.
  • 36
    Hancer VS, Diz-Kucukkaya R, Bilge AK et al. The association between factor XIII Val34Leu polymorphism and early myocardial infarction. Circ J 2006; 70: 23942.
  • 37
    Aleksic N, Ahn C, Wang YW et al. Factor XIIIA Val34Leu polymorphism does not predict risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2002; 22: 34852.
  • 38
    Warner D, Mansfield MW, Grant PJ. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography. Thromb Haemost 2001; 85: 40811.
  • 39
    Voko A, Bereczky Z, Katona E, Adány R, Muszbek L. Factor XIII Val34Leu variant protects against coronary artery disease. Thromb Haemost 2007; 97: 45863.
  • 40
    Wells P, Anderson J, Scarvelis D, Doucette SP, Gagnon F. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol 2006; 164: 1019.
  • 41
    Ivaskevicius V, Seitz R, Kohler HP et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007; 97: 91421.
  • 42
    Seitz R, Duckert F, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U. ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group. Semin Thromb Hemost 1996; 22: 4158.
  • 43
    Inbal A, Dardik R. Role of coagulation factor XIII in angiogenesis and tissue repair. Pathophysiol Haemost Thromb 2006; 35: 1625.
  • 44
    Asahina T, Kobayashi T, Takeuchi K, Kanayama N. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv 2007; 62: 25560.
  • 45
    Tosetto A, Castaman G, Rodeghiero F. Acquired plasma factor XIII deficiencies. Haematologica 1993; 78: 510.
  • 46
    Oertel K, Hunfeld A, Specker E et al. A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma. Anal Biochem 2007; 367: 1528.
  • 47
    Parameswaran KN, Cheng XF, Chen EC, Velasco PT, Wilson JH, Lorand L. Hydrolysis of γ:ε isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa. J Biol Chem 1997; 272: 103117.
  • 48
    Robberts HR, Bingham MD. Other coagulation factor deficiencies. In: LoscalzoJ, SchaferAI, eds. Thrombosis and Haemorrhage, 3rd edn. Philadelphia, PA: Lippincott Williams and Wilkins, 2003: 5923.
  • 49
    Nugent D. Prophylaxis in rare coagulation disorder: factor XIII deficiency. Thromb Res 2006; 118: S238.
  • 50
    Ichinose A, Asahina T, Kobayshi T. Congenital blood coagulation factor XIII deficiency and perinatal management. Curr Drug Targets 2005; 6: 5419.
  • 51
    Lovejoy A, Reynolds T, Visich J et al. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood 2006; 108: 5762.
  • 52
    Kangsadalampai S, Yenchitsomanus P, Chelvanayagam G et al. Identification of a new mutation (Gly420Ser), distal to the active site, that leads to factor XIII deficiency. Eur J Haematol 2000; 65: 27984.
  • 53
    Anwar R, Stewart AD, Miloszewski KJ, Losowsky MS, Markham AF. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol 1995; 91: 72835.
  • 54
    Duan B, Wang H, Chu H et al. [Identification of two novel mutation in two Chinese hereditary coagulation factor XIII deficiency families]. Zhonghua Xue Ye Xue Za Zhi 2002; 23: 11720.
  • 55
    Peyvandi F, Tagliabue L, Menegatti M et al. Phenotype–genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat 2004; 23: 98107.
  • 56
    Anwar R, Minford A, Gallivan L, Trinh CH, Markham AF. Delayed umbilical bleeding – a presenting feature for factor XIII deficiency: clinical features, genetics, and management. Pediatrics 2002; E32: 17.
  • 57
    Schroeder V, Meili E, Cung T, Schmutz P, Kohler HP. Characterisation of six novel A subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder. Thromb Haemost 2006; 95: 7784.
  • 58
    Standen GR, Bowen DJ. Factor XIII ABristol 1: detection of a nonsense mutation (Arg171[RIGHTWARDS ARROW]stop codon) in factor XIII A subunit deficiency. Br J Haematol 1993; 85: 76972.
  • 59
    Vysokovsky A, Saxena R, Landau M et al. Seven novel mutations in the factor XIII A–subunit gene causing hereditary factor XIII deficiency in 10 unrelated families. J Thromb Haemost 2004; 2: 17907.
  • 60
    Birben E, Oner C, Oner R, Altay C, Gurgey A. Identification of an inframe deletion and a missense mutation in the factor XIIIA gene in two Turkish patients. Eur J Haematol 2003; 71: 3943.
  • 61
    Mikkola H, Syrjala M, Rasi V et al. Deficiency in the A–subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 51725.
  • 62
    Mikkola H, Yee VC, Syrjala M et al. Four novel mutations in deficiency of coagulation factor XIII: consequences to epsression and structure of the A–subunit. Blood 1996; 87: 14151.
  • 63
    Ichinose A, Tsukamoto H, Izumi T et al. Arg260–Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics. Br J Haematol 1998; 101: 26472.
  • 64
    Kangsadalampai S, Chelvanayagam G, Baker R, Tiedemann K, Kuperan P, Board PG. Identification and characterization of two missense mutations causing factor XIIIA deficiency. Br J Haematol 1999; 104: 3743.
  • 65
    Onland W, Boing AN, Meijer AB et al. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family. Haemophilia 2005; 11: 53947.
  • 66
    Souri M, Yee VC, Kasai K et al. Novel Y283C mutation of the A subunit for coagulation factor XIII: molecular modeling predicts its impaired protein folding and dimer formation. Br J Haematol 2001; 113: 6524.
  • 67
    Anwar R, Gallivan L, Miloszewski KJ, Markham AF. Factor XIII deficiency causing mutations, Ser295Arg, in exon 7 of the factor XIIIA gene. Thromb Haemost 2000; 84: 5914.
  • 68
    Anwar R, Gallivan L, Richards M, Khair K, Wright M, Minford A. Factor XIII deficiency: new nonsense and deletion mutations in the human factor XIIIA gene. Haematologica 2005; 90: 171820.
  • 69
    Anwar R, Gallivan L, Trinh C, Hill F, Markham A. Identification of a new Leu354Pro mutation responsible for factor XIII deficiency. Eur J Haematol 2001; 66: 1336.
  • 70
    Izumi T, Nagaoka U, Saito T, Takamatsu J, Saito H, Ichinose A. Novel deletion and insertion mutations cause splicing defects, leading to severe reduction in mRNA levels of the A subunit in severe factor XIII deficiency. Thromb Haemost 1998; 79: 47985.
  • 71
    Kangsadalampai S, Farges-Berth A, Caglayan SH, Board PG. New mutations causing premature termination of translation in the A subunit gene of coagulation factor XIII. Thromb Haemost 1996; 76: 13942.
  • 72
    Niiya T, Osawa H, Bando S et al. A complete deficiency of coagulation factor XIII A–subunit due to a novel compound heterozygote of Ser413Leu missense and an nt 38 (ins G) frameshift mutation. Br J Haematol 1999; 107: 7725.
  • 73
    Aslam S, Yee VC, Naraganan S, Duraisamy G, Standen GR. Structural analysis of a missense mutation (Val414Phe) in the catalytic core domain of the factor XIII(A) subunit. Br J Haematol 1997; 98: 34652.
  • 74
    Kangsadalampai S, Yenchitsomanus P, Chelvanayagam G, Sawasdee N, Laosombat V, Board P. Identification of a new mutation (Gly420Ser), distal to the active site, that leads to factor XIII deficiency. Eur J Haematol 2000; 65: 27984.
  • 75
    Birben E, Oner R, Oner C, Gumruk F, Altay C, Gurgey A. Mutations in coagulation factor XIII A gene in three Turkish patients: two novel mutations and a known insertion. Br J Haematol 2002; 118: 27881.
  • 76
    Takahashi N, Tsukamoto H, Umeyama H, Castaman G, Rodeghiero F, Ichinose A. Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system. Blood 1998; 91:28308.
  • 77
    Inbal A, Yee VC, Kornbrot N, Zivelin A, Brenner B, Seligsohn U. Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit-A gene in three unrelated Palestinian Arab families. Thromb Haemost 1997; 77: 10627.
  • 78
    Aslam S, Poon MC, Yee VC, Bowen DJ, Standen GR. Factor XIIIA Calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit. Br J Haematol 1995; 91: 4527.